Acesso Livre 1

EBOLA

(1)
WARFIELD, K. L. et al. Vaccinating captive chimpanzees to save wild chimpanzees. PNAS, United States, v. 111, n. 24, p. 8873-8876, Jun. 2014.

Leia o artigo

Acesso Livre 2

(2)
GATHERER, D. The 2014 Ebola virus disease outbreak in West Africa. Journal of General Virology, London, v. 95, n. 8, p. 1619-1624, Aug. 2014.

Leia o artigo

(3)
LI, Y. H., CHEN, S. P. Evolutionary history of ebola virus. Epidemiology and Infection, Cambridge, v. 142, n. 1, p. 1138-1145, Jan. 2014.

Leia o artigo

(4)
UEBELHOER, L. S. et al. A High-throughput, luciferase-based reverse genetics systems for identifying inhibitors of Marburg and ebola viruses. Antiviral Research, [S.l.], v. 106, p. 86-94, Jun. 2014.

Leia o artigo

(5)
GARRISON, A. R. et al. The cyanobacterial lectin scytovirin displays potent in vitro and in vivo activity against Zaire Ebola virus. Antiviral Research, [S.l.], v. 112, p. 1-7, Dez. 2014.

Leia o artigo

(6)
Case fatality rates of Ebola virus disease: a meta-analysis of World Health Organization data. Médecine el Maladies Infectieuses, Paris, v. 44, n. 9, p. 412-416, Sep. 2014.

Leia o artigo

(7)
WANG, Y., LIU, Z., DAI, Q. A highly immunogenic fragment derived from Zaire Ebola virus glycoprotein elicits effective neutralizing antibody. Virus Research, Madrid, v. 189, p. 254-261, Aug. 2014.

Leia o artigo

(8)
CHOWELL, G., NISHIURA, H. Transmission dynamics and control of ebola virus diasease (EVD): a review. BMC Medicine, London, v. 12, p. 196, Out. 2014.

Leia o artigo

(9)
HOENE, T.; FELDMANN, H. Ebolavirus in West Africa, and the use of experimental therapies or vaccines. BioMed Central, London, v. 12, p. 80, Sep. 2014.

Leia o artigo

(10)
O’BRIEN, L. et al. Vaccination with recombinant adenoviruses expressing ebola virus glycoprotein elicits protection in the interferon alphabeta receptor knock-out mouse. Virology, Washington, v. 452-453, p. 324-333, Mar. 2014.

Leia o artigo